Trends in insulin resistance: insights into mechanisms and therapeutic strategy

M Li, X Chi, Y Wang, S Setrerrahmane… - Signal transduction and …, 2022 - nature.com
The centenary of insulin discovery represents an important opportunity to transform diabetes
from a fatal diagnosis into a medically manageable chronic condition. Insulin is a key …

[HTML][HTML] An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease

E Lee, H Korf, A Vidal-Puig - Journal of hepatology, 2023 - Elsevier
Alongside the liver, white adipose tissue (WAT) is critical in regulating systemic energy
homeostasis. Although each organ has its specialised functions, they must work …

Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity

W Ying, M Riopel, G Bandyopadhyay, Y Dong… - Cell, 2017 - cell.com
MiRNAs are regulatory molecules that can be packaged into exosomes and secreted from
cells. Here, we show that adipose tissue macrophages (ATMs) in obese mice secrete …

Metabolic flexibility as an adaptation to energy resources and requirements in health and disease

RL Smith, MR Soeters, RCI Wüst… - Endocrine …, 2018 - academic.oup.com
The ability to efficiently adapt metabolism by substrate sensing, trafficking, storage, and
utilization, dependent on availability and requirement, is known as metabolic flexibility. In …

PPARγ signaling and metabolism: the good, the bad and the future

M Ahmadian, JM Suh, N Hah, C Liddle, AR Atkins… - Nature medicine, 2013 - nature.com
Thiazolidinediones (TZDs) are potent insulin sensitizers that act through the nuclear
receptor peroxisome proliferator-activated receptor-γ (PPARγ) and are highly effective oral …

Macrophages, immunity, and metabolic disease

JC McNelis, JM Olefsky - Immunity, 2014 - cell.com
Chronic, low-grade adipose tissue inflammation is a key etiological mechanism linking the
increasing incidence of type 2 diabetes (T2D) and obesity. It is well recognized that the …

Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis

V Kumar, X Xin, J Ma, C Tan, N Osna… - Advanced drug delivery …, 2021 - Elsevier
Type 2 diabetes mellitus (T2DM) associated non-alcoholic fatty liver disease (NAFLD) is the
fourth-leading cause of death. Hyperglycemia induces various complications, including …

The cellular and signaling networks linking the immune system and metabolism in disease

O Osborn, JM Olefsky - Nature medicine, 2012 - nature.com
It is now recognized that obesity is driving the type 2 diabetes epidemic in Western
countries. Obesity-associated chronic tissue inflammation is a key contributing factor to type …

PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells

D Cipolletta, M Feuerer, A Li, N Kamei, J Lee… - Nature, 2012 - nature.com
Obesity and type-2 diabetes have increased markedly over the past few decades, in parallel.
One of the major links between these two disorders is chronic, low-grade inflammation …

Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes

RE Soccio, ER Chen, MA Lazar - Cell metabolism, 2014 - cell.com
Type 2 diabetes is caused by insulin resistance coupled with an inability to produce enough
insulin to control blood glucose, and thiazolidinediones (TZDs) are the only current …